HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janet M Leeds Selected Research

Janet M Leeds Research Topics

Disease

5Hemorrhage
01/2020 - 12/2015
4Poxviridae Infections
01/2013 - 11/2010
2Neoplasms (Cancer)
01/2019 - 01/2019
2Infections
04/2013 - 03/2013
2Smallpox (Variola)
03/2013 - 01/2013
1Shock
08/2019
1Wounds and Injuries (Trauma)
08/2019
1Multiple Trauma (Multiple Injuries)
08/2019
1Inflammation (Inflammations)
01/2019
1Venous Thrombosis (Deep-Vein Thrombosis)
03/2017
1Venous Thromboembolism
03/2017
1Pulmonary Embolism
03/2017
1Renal Insufficiency (Renal Failure)
03/2017

Drug/Important Bio-Agent (IBA)

4tecovirimatIBA
03/2013 - 11/2010
3PRT064445IBA
01/2020 - 01/2018
3AnticoagulantsIBA
01/2020 - 01/2018
3Factor Xa (Coagulation Factor Xa)IBA
01/2020 - 09/2017
3Antiviral Agents (Antivirals)IBA
01/2013 - 11/2010
2apixabanIBA
01/2020 - 08/2019
2Factor Xa InhibitorsIBA
08/2019 - 12/2015
24- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA
01/2019 - 01/2019
2Janus Kinase InhibitorsIBA
01/2019 - 01/2019
1RivaroxabanIBA
01/2020
1edoxabanIBA
01/2018
1fibrin fragment D (D-dimer)IBA
03/2017
1betrixabanIBA
03/2017
1Enoxaparin (Lovenox)FDA LinkGeneric
03/2017
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2017
1VaccinesIBA
04/2013

Therapy/Procedure

1Anticoagulation Reversal
01/2020
1Therapeutics
04/2013
1Oral Administration
01/2013